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UNITED KINGDOM; and 4University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester, UNITED KINGDOM 
ABSTRACT 
CULLEN, T., G. THOMAS, and A. J. WADLEY. Sleep Deprivation: Cytokine and Neuroendocrine Effects on Perception of Effort. Med. Sci. 
Sports Exerc., Vol. 52, No. 4, pp. 909–918, 2020. Introduction: An increased perception of effort and subjective fatigue are thought to be 
central to decreased exercise performance observed after disrupted sleep. However, there is limited understanding of mechanisms that under-
pin these phenomena. We investigated the role of interleukin-6 (IL-6), the soluble IL-6 receptor, and neuroendocrine factors (cortisol, adren-
aline, noradrenaline, and brain-derived neurotropic factor) in mediating these responses at rest and during exercise. Methods: In a randomized 
order, 10 healthy active men completed three experimental trials following different sleep conditions: a single night of sleep deprivation, par-
tial sleep deprivation equivalent to 4 h of sleep, and normal sleep. The experimental sessions consisted of physiological and perceptual mea-
surements of exercise intensity throughout 45-min moderate intensity and 15-min maximal effort cycling. Cytokine and neuroendocrine 
factors were assessed at rest and in response to exercise. Results: Sleep deprivation resulted in increased resting IL-6, lower blood glucose, 
increased perceived fatigue and perception of effort, lower free-living energy expenditure, and reduced maximal exercise performance. In con-
trast, sleep deprivation did not alter physiological, cytokine, or neuroendocrine responses to exercise. Variations in the resting concentration of 
IL-6 were associated with lowered blood glucose, an increased perception of effort, and impaired exercise performance. Resting concentrations 
of cortisol, adrenaline, noradrenaline, and BNDF showed subtle interactions with specific aspects of mood status and performance but were not 
affected by sleep deprivation. There were minimal effects of partial sleep deprivation. Conclusions: These findings demonstrate that cytokine 
and neuroendocrine responses to exercise are not altered by sleep deprivation but that changes in the resting concentration of IL-6 may play a 
role in altered perception of effort in this context. Key Words: SLEEP DEPRIVATION, FATIGUE, MOOD, EXERCISE, BDNF, IL-6 
It is widely recognized that poor sleep can have a negative ef- biological mechanisms involved in these phenomena remain fect on a wide array of psychological and physiological func- poorly understood. An improved understanding of the mecha-tions (1). Numerous studies have also investigated the effect nisms involved in these processes may lead to improved manage-
of acute sleep deprivation on physical performance, and although ment of or countermeasures to the negative effects of poor sleep. 
there is a broad consensus that physiological responses to exer- There is a growing interest in the role of cytokines and neu-
cise remain largely unchanged, an elevation in RPE is thought roendocrine signaling factors (e.g., cortisol, adrenaline, nor-
be a crucial factor mediating impaired exercise performance (2). adrenaline, and brain-derived neurotropic factor (BDNF)) 
Interestingly, there is evidence that increased perception of task and their relationship to changes in mood and sensation of fa-
difficulty is a major factor in impaired performance of not only tigue (5). Mechanistic studies are often difficult in humans, yet 
physical (3) but also cognitive tasks (4), and yet the underpinning there is good evidence that at least some of these signaling fac-
tors can readily cross the blood–brain barrier and that even a 
small change in the circulating concentration can have signal-Address for correspondence: Tom Cullen, Ph.D., Centre for Sport, Exercise 
and Life Sciences, Coventry University, Priory Street, Coventry CV1 5FB, ing effects within the brain (6). Indeed, recent evidence sug-
United Kingdom; E-mail: ad0189@coventry.ac.uk. gests that the circulating concentration of BDNF is positively 
Submitted for publication July 2019. related to mood and cognition (7), whereas a negative relation-
Accepted for publication October 2019. ship has been observed between interleukin-6 (IL-6) and mood 
0195-9131/20/5204-0909/0 (8). This is particularly important given that impaired mood 
MEDICINE & SCIENCE IN SPORTS & EXERCISE® status and well-being are some of the most consistently re-
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. ported psychological effects of sleep deprivation (9,10), and 
on behalf of the American College of Sports Medicine. This is an open-access 
it is plausible that impairments in athletic performance may article distributed under the terms of the Creative Commons Attribution-Non 
Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible be mediated in part by alterations in mood brought about by 
to download and share the work provided it is properly cited. The work cannot be changes in cytokine or neuroendocrine signaling. 
changed in any way or used commercially without permission from the journal. Recent evidence has also documented a relationship be-
DOI: 10.1249/MSS.0000000000002207 tween IL-6 and BDNF after disrupted sleep (11,12). Reports 
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of lower circulating concentrations of BDNF are primarily 
from epidemiological studies and could therefore be confounded 
by other factors (e.g., diet or levels of physical activity) (11). Pre-
vious well-conducted studies have shown that sleep deprivation 
can cause an elevation in IL-6 in response to acute sleep depriva-
tion (12); however, there is a limited study of soluble IL-6 recep-
tor (sIL-6R) in this context. The effects of IL-6 on the brain 
likely extend beyond mood and may affect the sensation of fa-
tigue, which could have important consequences for exercise 
performance (13). This may be important considering that recent 
evidence suggests that some of the fatigue-inducing effects of 
IL-6 may be related to “trans-signaling” through sIL-6R (14). 
Our group recently provided novel evidence that aspects of 
IL-6 “trans-signaling” through the sIL-6R were related to mea-
sures of sleep, mood, and perception of fatigue in elite athletes 
during a prolonged training period (15). However, this study 
only examined resting measures and was limited in terms of 
the breadth of the analysis. In fact, the majority of studies have 
focused on resting concentrations of cytokine and neuroendo-
crine responses after sleep deprivation, whereas there is consider-
ably less research assessing partial sleep deprivation, which may 
be more similar to what is experienced in the real world. Further-
more, very few studies have investigated any potential divergent 
responses to exercise. Therefore, the aim of the current study was 
to (a) characterize the effects of partial and complete sleep depri-
vation on selected cytokine and neuroendocrine responses both at 
rest and in response to exercise and (b) to investigate their rela-
tionship with subjective fatigue and effort perception. 
METHODS 
Before commencement of the study, the University Health 
Sciences Research Ethics Committee granted ethical approval 
(project code SH16170020-R) for all methods and ensured that 
the study conformed to the Declaration of Helsinki. All partici-
pants gave written informed consent to participate in the study. 
Participants 
Participants comprised 10 recreationally active men. Their 
age, height, weight, and maximal oxygen uptake were as fol-
lows (mean ± SD): 27 ± 6 yr, 182 ± 8 cm, 88 ± 8 kg, and 
43 ± 7 mL·kg−1·min−1. As part of the screening procedures, par-
ticipants completed departmental health screening and physical 
activity questionnaires and the Pittsburgh Sleep Quality Index 
(16). To take part in the study, participants needed to declare 
themselves free from injury and illness for a minimum of 2 wk 
before commencement of the study and be identified as having 
normal sleep pattern based on a Global Pittsburgh Sleep Quality 
Index score <5 (16). Participants were required to not be taking 
any medication known to interfere with normal inflammatory re-
sponses (e.g., nonsteroidal anti-inflammatory drugs, etc.). 
Study Design 
This study comprised a randomized, repeated-measures cross-
over design. Participants completed preliminary testing to ascer-
tain a measurement of aerobic fitness (maximal oxygen uptake 
(V˙ O2max)) and were provided with an actigraph (Actiheart, 
Version 2.2; CamNTech Ltd., Cambridge, United Kingdom), 
which was worn throughout the study and used to assess sleep 
and activity patterns throughout. Energy expenditure was cal-
culated in the 24-h period before each test session, the 12 h 
on the same day of each test session, and the 24-h period the 
day after each test to assess activity patterns before and after 
each condition. In these conditions, energy expenditure was 
measured using an Actiheart, which integrates accelerometer 
and heart rate (HR) data (17). 
Participants also completed a sleep diary, estimating the 
quality of their sleep on a 5-point scale, and the time at which 
they went to sleep and awoke the day before each test session. 
After at least a 3-d rest, participants completed three further 
experimental trials with manipulated sleep routines in a ran-
domized and counterbalanced order with a further 7 d between 
each subsequent experimental trial. To account for the known 
effects of time of day on hypothalamic–pituitary–adrenal axis, 
sympathetic nervous system, mood, and inflammatory signal-
ing, experimental test sessions were completed at the same 
time of day on each occasion (between 7:00 and 9:00 AM). 
The experimental trials consisted of a control condition (CON), 
partial sleep deprivation (PART), and a night of no sleep 
(DEP), which was equivalent to 24 h of sleep deprivation. Be-
fore CON, participants obtained a normal night sleep (7–9 h)  
in their own bed. For PART and DEP, participants arrived 
at the laboratory the evening before testing and remained 
under the supervision of the researchers until testing was com-
pleted the following day. For PART, participants were allowed 
a 4-h sleep opportunity in a prepared bedroom, commencing at 
their normal bedtime, and were then awoken 4 h later. Once 
awake, participants remained under the supervision of the re-
searchers at all times, to ensure that participants remained 
awake throughout the trial. Participants carried out sedentary 
activities such as watching films, reading, and talking to the re-
searchers. Throughout this period, participants were permitted 
to drink water ad libitum, but were instructed to abstain from 
food for 12 h before the commencement of each test session 
and to replicate their diet in between conditions. 
During each experimental trial (detailed hereinafter), partic-
ipants initially completed questionnaires for the assessments 
of mood states and a sleep diary. After a brief rest, participants 
then completed an aerobic exercise bout comprising 45 min of 
standardized submaximal exercise, immediately followed by 
15-min self-paced maximal effort time trial where participants 
were encouraged to cycle as far as possible. Blood samples 
were taken at rest, at the end of the submaximal exercise, im-
mediately after the completion of maximal exercise, and after 
30 min of recovery. Blood samples were then later used for the 
assessment of circulating concentrations of specific cytokines 
and immune-endocrine markers. A schematic representation 
of the experimental testing is provided in Figure 1. 
Preliminary Testing 
Participants completed an incremental exercise test on an 
electromagnetically braked cycle ergometer (Lode Excalibur, 
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FIGURE 1—A schematic representation of the experimental trial. 
Groningen, the Netherlands). Expired gases were continu-
ously measured using an online gas analysis system (Cortex 
Biophysik Metalyzer, Leipzig, Germany), whereas HR was 
measured via a short-range telemetric HR monitor (RS400; 
Polar Electro, Espoo, Finland). The protocol consisted of 
3-min stages, starting at 100 W and increased incrementally 
by 30 W each stage, until volitional exhaustion. Participants 
were instructed to maintain a pedal cadence of 80 rpm through-
out the test. V˙ O2max was recorded as the highest 30-s period of 
oxygen consumption. Oxygen consumption values obtained 
throughout each participant’s test were used to plot a linear re-
gression of power output versus oxygen consumption, and the 
resultant equation was then used to determine standardized 
power outputs for subsequent test sessions. After the maximal 
test, participants were then familiarized with tests to be con-
ducted in subsequent sessions. 
Experimental Procedures 
Subjective fatigue and mood states. Participants 
completed a modified and shortened version of the Profile 
of Mood States questionnaire (18) to assess their subjective 
level of fatigue and mood status. Participants scored them-
selves on a 1–5 scale in the following categories: tense, mis-
erable, angry, lively fatigued, and confused. Before completing 
the questionnaire, participants were provided with a full expla-
nation of each question. Questionnaires of this type have been 
shown to be reliable and valid for assessing fatigue in sporting 
contexts (19). 
Aerobic exercise session. The aerobic exercise session 
consisted of a 45-min of submaximal cycling at a constant 
power output equivalent to 60% of the individuals V˙ O2max. 
This was immediately proceeded by a 15-min maximal effort 
self-paced time trial, whereby participants were instructed to 
cycle as far as possible in the given time. This allowed for 
the comparison of physiological and biochemical responses 
to both standardized submaximal exercise and maximal exer-
cise within the same experimental protocol. Distance traveled 
was calculated and expressed as a percentage of the distance 
that individual achieved in the control condition. Respiratory 
gases and HR were measured continuously throughout each 
trial and expressed as a percentage of individual’s maximum 
value measured during the maximal incremental test. Every 
5-min RPE (20), blood lactate and glucose were measured. 
Lactate and glucose were measured using an automated bench-
top analyzer (Biosen C-Line Clinic; EKF-diagnostic GmbH, 
Barleben, Germany) from capillary blood samples, obtained 
in the final 30 s of each 5-min period. 
Blood Collection and Analysis 
A cannula (Becton, Dickson & Company, Oxford, United 
Kingdom) was inserted into the antecubital vein of the arm. 
Whole blood (10 mL per time point) samples were collected 
into K3EDTA vacutainers (Greiner Bio-one; Frickenhausen, 
Germany) at rest (PRE), in the final 3-min of the submaximal 
portion of the exercise trial (DUR), at cessation of the maximal 
exercise (POST), and 30 min into recovery (30 MIN). Samples 
were then centrifuged at 4°C, 3000g for 10 min, and the resul-
tant plasma was separated into aliquots and stored at −80°C, 
until subsequent analysis. Commercially available enzyme-
linked immunosorbent assay kits (Biotechne, Abingdon, 
United Kingdom) were used to quantify the concentration of 
IL-6, sIL-6R, cortisol, BDF, adrenaline, and noradrenaline. 
All samples were analyzed in duplicate, and the manufac-
turer’s instructions were adhered to at all times. To produce 
concentrations that were within the dynamic range of each as-
say, plasma samples were diluted with a commercially avail-
able diluent (DY997; R&D Systems Ltd) before analysis of 
sIL-6R (1:100), cortisol, BDNF, adrenaline, and noradrena-
line (all, 1:20). To minimize variation between assays, all sam-
ples from an individual participant were analyzed in the same 
assay. In our hands, the intra-assay coefficients of variation for 
these assays were as follows: IL-6, 4.1% ± 2.6%; sIL-6R, 
2.1% ± 1.8%; cortisol, 6.4% ± 4.7%; BDNF, 3.2% ± 2.2%; 
adrenaline, 4.0% ± 2.5%; and noradrenaline, 4.0% ± 4.1%. 
The concentration of each analyte was determined in relation to 
a four-parameter standard curve (GraphPad Prism, San Diego, 
CA) and were corrected for changes in plasma volume based 
on established criteria (21). 
Statistical Analysis 
The Shapiro–Wilk test was used to test for normality in 
scale data. For resting and summary data, one-way repeated-
measures ANOVAs or nonparametric Friedman test was used 
where appropriate. A two-way repeated-measures ANOVA 
(sleep condition–time) was used to assess the effect of sleep 
condition on the exercise-induced responses for IL-6, sIL-
6R, cortisol, BDNF, adrenaline, and noradrenaline. When data 
were nonnormally distributed, log transformations were per-
formed before analysis, and the respective data were then back 
transformed for ease of presentation in figures. When main 
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effects were identified, post hoc analysis was performed using 
simple pairwise comparisons with Bonferroni adjustment 
or Dunn’s test where appropriate. Pearson correlation and 
Spearman rank were used to assess the relationship between 
parametric and nonparametric data, respectively. Effect sizes 
for main effects are presented as η2. Statistical analyses were 
undertaken using GraphPad Prism and SPSS (IBM SPSS Sta-
tistics for Windows, Version 25.0; IBM Corp., Armonk, NY). 
All data are presented as mean ± SD unless otherwise stated, 
and statistical significance was set at P < 0.05.  
RESULTS 
Sleep and energy expenditure. Participants reported 
sleeping significantly more (467 ± 42 min) for CON than 
PART (217.5 ± 21 min) and DEP (0 ± 0), respectively 
(F = 674.9,  P < 0.001,  η2 = 0.98), with participants falling 
asleep later before PART than CON (P = 0.039; mean  differ-
ence, 19 min; 95% confidence interval (CI), 0.9 to −38 min). 
Sleep quality was significantly better for CON (3.3 ± 0.8) than 
for PART (2.6 0 ± 0.7) and DEP (0 ± 0; F = 98.35,  P < 0.001,  
η2 = 0.92). There was no significant difference in total energy 
expenditure in the 24 h before the test (2533 kcal for CON vs 
2542 kcal for PART vs 2761 kcal for CON, P > 0.05).  Energy  
expenditure in the 12 h after the experimental trials showed a 
main effect of condition (F = 5.2,  P = 0.018,  η2 = 0.39) and 
was significantly lower in DEP than in CON (mean differ-
ences, −208 kcal; 95% CI, −404 to −13 kcal) and PART (mean 
difference, −200 kcal; −396 to −5 kcal), but were not signif-
icantly different in the 24-h period the day after each trial 
(2681 ± 361 kcal for CON, 2697 ± 514 kcal for PART, 
2547 kcal for DEP). 
Resting measurements. The results of subjective fa-
tigue and mood status after each of the sleep conditions are 
summarized in Table 1. Participants reported being signifi-
cantly more miserable (P = 0.006) and confused (P = 0.019)  
after DEP than CON, while also feeling less lively (P = 0.019). 
Participants reported being significantly more fatigued after 
PART and DEP than CON (P = 0.001).  
There were no significant differences in the resting concen-
tration of sIL-6R, cortisol, BDNF, adrenaline, or noradrena-
line between CON, PART, and DEP. There was a significant 
effect of condition on resting IL-6 (F = 5.6,  P = 0.012,  
η2 = 0.39) and blood glucose (F = 4.2,  P = 0.032,  η2 = 0.31;  
Figs. 2A, B, respectively). Post hoc testing revealed signifi-
cantly higher IL-6 after DEP (0.95 ± 0.37 pg·mL−1) versus  
TABLE 1. Comparisons of fatigue and mood state after the three different sleep conditions. 
CON PART DEP 
Tense  0.7 ± 0.7  1.1 ± 0.9  1.1 ± 0.9  
Miserable 0.0 ± 0.0 0.2 ± 0.4 1.1 ± 1.3* 
Angry  0.0 ± 0.0  0.0 ± 0.0  0.2 ± 0.6  
Lively 1.9 ± 1.0 1.5 ± 0.7 0.6 ± 0.8* 
Fatigued  0.7 ± 0.5  2.0 ± 0.7*  2.7 ± 1.5*  
Confused  0.1 ± 0.3  0.5 ± 0.7  1.3 ± 1.6*  
Sleep conditions comprised normal night of 7- to 9-h sleep (CON), a 4-h sleep opportunity 
at the start of the night (PART), and a single night of sleep deprivation (DEP). 
*Significantly different from control (P < 0.05). 
FIGURE 2—Resting concentration of IL-6 (A) and blood glucose (B) after 
three different sleep conditions. Sleep conditions comprised normal night 
of 7- to 9-h sleep (CON), a 4-h sleep opportunity at the start of the night 
(PART), and a single night of sleep deprivation (DEP). C, Correlation be-
tween resting IL-6 and blood glucose. *Significantly different from CON. 
CON (0.62 ± 0.22 pg·mL−1; mean difference, −0.33 pg·mL−1; 
95% CI, −0.59 to 0.06 pg·mL−1) and a significant de-
crease in blood glucose (4.2 ± 0.3 mmol·L−1 for DEP vs 
4.6 ± 0.5 mmol·L−1 for CON; mean difference, 0.44 mmol·L−1; 
95% CI, 0.01–0.88 mmol·L−1). Correlation analysis revealed 
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TABLE 2. Summary of physiological and perceptual responses to a 45-min submaximal 
constant load cycling exercise and a 15-min self-paced maximal effort time trial after three 
separate sleep conditions. 
Submaximal Exercise CON PART DEP 
Mean V˙ O2, %Max 62.5 ± 5.8 61.8 ± 5.7 61.1 ± 4.4 
Mean HR, %Max 73.9 ± 3.8 73.9 ± 3.8 72.5 ± 4.3 
Mean RER 0.89 ± 0.03 0.88 ± 0.04 0.87 ± 0.03 
Mean Lactate, mmol·L−1 2.0 ± 0.7  1.9 ± 0.7  1.8 ± 0.6  
Mean RPE, A/U 11.8 ± 1.6 12.6 ± 0.9 13.4 ± 1.9* 
Maximal exercise 
Mean V˙ O2, %Max 85.4 ± 6.5 83.4 ± 6.2 78.5 ± 11.4* 
Mean HR, %Max 93.2 ± 2.2 91.5 ± 1.8 87.7 ± 6.1* 
Mean RER 0.96 ± 0.02 0.95 ± 0.03 0.92 ± 0.05* 
Mean lactate, mmol·L−1 5.4 ± 0.7  4.9 ± 1.1  4.3 ± 1.5*  
Mean RPE, A/U 18.1 ± 1.3 17.9 ± 0.9 18.5 ± 1.1 
*Significantly different from control (P < 0.05). 
a significant negative relationship between resting IL-6 and 
blood glucose (P = 0.02, r = −0.44; 95% CI, −0.7 to −0.07; 
see Fig. 2 for a summary). Subjective fatigue at rest was neg-
atively correlated with the total energy expenditure in the 12 h 
after the exercise (P = 0.01, r = −0.46; 95% CI, −0.75 to 
−0.04). Resting concentrations of IL-6 and sIL-6R were neg-
atively related (P = 0.01, r = −0.48; 95% CI, −0.72 to −0.12). 
Adrenaline was negatively related to subjective perception of 
fatigue at rest (P = 0.027, r = −0.43; 95% CI, −0.7 to −0.06), 
whereas noradrenaline was positively related to perceived “ten-
sion” (P = 0.027, r = 0.49; 95% CI, 0.07–0.77). BDNF was neg-
atively related to perceived rating of “miserableness” (P = 0.02, 
r = −0.46; 95% CI, −0.72 to −0.09) and positively related to per-
ceived “liveliness” (P = 0.025,  r = 0.44; 95% CI, 0.06–0.71). 
Physiological and perceptual responses to exer-
cise. Physiological and perceptual responses to exercise are 
summarized in Table 2, whereas Figure 3 provides a graphical 
demonstration of the differences between key physiological 
and perceptual responses to the different sleep conditions. 
There were no significant differences between any of the phys-
iological responses (mean oxygen uptake (V˙ O2), HR, RER, or 
lactate) between the three experimental conditions during the 
45-min constant load portion of the exercise, whereas percep-
tion of effort (as measured by mean RPE) was significantly 
higher in DEP (13.4 ± 1.9) than in CON (11.8 ± 1.6; P = 0.03).  
Physiological responses to maximal exercise were signifi-
cantly different between CON and DEP. There was a main ef-
fect of condition on mean V˙ O2 (F = 3.3,  P = 0.038,  η
2 = 0.3),  
which was significantly higher after CON (85.4% ± 5.5%) 
than DEP (78.5% ± 11.4%; mean difference, 7.7%; 95% CI, 
0.3%–14.9%). Similarly, there was a main effect of condition 
on distance traveled (F = 4.1,  P = 0.026,  η2 = 0.23), with  sig-
nificantly less distance traveled in DEP than in CON (mean 
difference, 11.4%; 95% CI, 1.2%–21.6%; Fig. 3C). Mean 
RPE during submaximal exercise was positively related to sub-
jective fatigue at rest (P < 0.001, r = 0.63; 95% CI, 0.33–0.81) 
and negatively related to the mean V˙ O2 achieved during the 
maximal exercise (P = 0.03,  r = −0.39; 95% CI, −0.66 to 
−0.04) and distance traveled (P = 0.006,  r = −0.49; 95% CI, 
−0.72 to −0.16). Subjective fatigue at rest was negatively re-
lated to mean V˙ O2 (P = 0.003,  r = −0.56; 95% CI, −0.77 to 
−0.22) and the distance traveled during maximal exercise 
FIGURE 3—The mean oxygen uptake (A) and perception of effort (B) 
during a 45-min submaximal constant load cycling exercise and a 
15-min self-paced maximal effort time trial after three experimental sleep 
conditions. C, Distance traveled in the 15-min self-paced maximal effort 
time trial (relative to the distance each person traveled in the control con-
dition). *A significant difference between CON and DEP. 
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(P < 0.001,  r = −0.7; 95% CI, −0.86 to −0.44). In contrast, dis-
tance traveled during maximal exercise was positively related 
to feeling of “liveliness” at rest (P < 0.001,  r = 0.66; 95% CI, 
0.37–0.83). 
There was a main effect of condition on mean HR (F = 5.0,  
P = 0.014,  η2 = 0.27), which was significantly higher after 
CON (93.2% ± 2.2%) than DEP (87.7% ± 6.1%; mean differ-
ence, 5.4%; 95% CI, 0.9%–9.8%). There was a main effect of 
condition on mean RER (F = 6.1,  P = 0.009,  η2 = 0.4), which 
was significantly higher after CON (85.4% ± 5.5%) than DEP 
(78.5% ± 11.4%; mean difference, 7.7%; 95% CI, 0.3%– 
14.9%). There was a main effect of condition on mean blood 
lactate (F = 3.8,  P = 0.039,  η2 = 0.3), which was signifi-
cantly higher after CON (5.4 ± 0.7 mmol·L−1) than DEP  
(4.3 ± 1.5 mmol·L−1; mean difference, 1.1 mmol·L−1; 95%  
CI, 0.05–2.1 mmol·L−1). In contrast to submaximal exer-
cise, there was no effect of condition on mean RPE during 
the maximal exercise. 
Cytokine and neuroendocrine responses to exer-
cise. Exercise-induced changes in plasma concentration of 
IL-6, sIL-6R, adrenaline, noradrenaline, cortisol, and BDNF 
are reported in Figure 4. For IL-6, there was a main effect of 
time (F = 84.1,  P < 0.0001,  η2 = 0.9), but no effect of condition 
(F = 1.2,  P = 0.3,  η2 = 0.05; Fig. 4A). IL-6 was significantly 
elevated immediately after the constant load portion of all ex-
ercise trials (P = 0.027; mean difference, 0.17 pg·mL−1; 95%  
CI, 0.018–0.32 pg·mL−1), continued to increase after the time 
trial (P < 0.0001; mean difference, 0.40 pg·mL−1; 95%  CI,  
0.032–0.49 pg·mL−1), and remained elevated 30 min after ces-
sation of the exercise. IL-6 concentration at rest was positively 
correlated with the mean RPE during the constant load portion 
of the exercise (P = 0.03,  r = 0.4; 95% CI, 0.04–0.67), but was 
negatively related to the mean V˙ O2 achieved during maximal 
exercise (P = 0.029,  r = −041; 95% CI, −0.67 to −0.05) 
and distance traveled during maximal exercise (P = 0.035,  
r = −0.39; 95% CI, −0.66 to −0.01). In contrast distance cycled 
FIGURE 4—Plasma IL-6 (A), sIL-6R (B), adrenaline (C), noradrenaline (D), cortisol (E), and BDNF (F) responses to exercise after three different sleep 
conditions. aSignificantly different from PRE. bSignificantly different from DUR. cSignificantly different from POST. dSignificantly different from 30 MIN. 
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was positively related to postexercise adrenaline concentration 
(P = 0.038,  r = 0.39; 95% CI, 0.023–0.66). 
The change in IL-6 from CON accounted for 25% of the 
variance in the mean V˙ O2 achieved during maximal exercise 
and 22% of the distance cycled. sIL-6R showed a main effect 
of time (F = 5.8,  P = 0.005,  η2 = 0.46), with no main effect of 
condition (F = 1.6,  P = 0.23,  η2 = 0.19). There was a trend for 
elevated sIL-6R after the time trial and 30 MIN; however, neither 
reached statistical significance (P = 0.11 and  P = 0.08, respec-
tively; Fig. 4B). sIL-6R concentration at rest was negatively cor-
related with the mean RPE during the constant load portion of the 
exercise (P = 0.009, r = −0.49; 95% CI, −0.73 to −0.14). Adren-
aline showed a significant main effect of time (F = 14.9, 
P < 0.0001, η2 = 0.15), with no main effect of condition 
(F = 0.4, P = 0.67, η2 = 0.03; Fig. 4C). Adrenaline was signif-
icantly increased at each time point compared with rest, 
peaking immediately after the time trial (P = 0.001; mean dif-
ference, 0.72 ng·mL−1; 95% CI, 0.4–1.0 ng·mL−1). Noradren-
aline showed a significant main effect of time (F = 30.7, 
P < 0.0001, η2 = 0.39), with no main effect of condition 
(F = 0.6, P = 0.5, η2 = 0.01; Fig. 4D). Post hoc tests revealed 
that noradrenaline was increased from rest at each time point, 
peaking immediately after time trial (P < 0.0001; mean differ-
ence, 2.2 ng·mL−1; 95% CI, 1.5–2.8 ng·mL−1). The resting 
concentration of noradrenaline was negatively correlated with 
the mean RPE during the constant load portion of the exercise 
(P = 0.04, r = −0.46; 95% CI, −0.75 to −0.02). BDNF showed 
a significant main effect of time (F = 23.2, P < 0.0001, 
η2 = 0.22), with no effect of condition (F = 0.02, P = 0.98, 
η2 = 0.008). BDNF was significantly elevated at each time 
point after exercise, peaking immediately after time trial 
(P = 0.002; mean difference, 3090 pg·mL−1; 95%  CI,  
1210–4970 pg·mL−1). Cortisol displayed significant main ef-
fects of time (F = 6.2,  P = 0.002,  η2 = 0.41) and condition 
(F = 3.8,  P = 0.04, η2 = 0.29; Fig. 4E). However, after a correc-
tion for multiple comparisons, there were no clear patterns to the 
variation of the data. Cortisol concentration at rest was posi-
tively correlated with the mean RPE during the constant load 
portion of the exercise (P = 0.002, r = 0.56; 95% CI, 0.24–0.77). 
DISCUSSION 
This study investigated the role of selected cytokine and 
neuroendocrine factors in altered physiological and perceptual 
responses to exercise after partial and complete sleep depriva-
tion. A single night of sleep deprivation led to an increased 
perception of fatigue, impaired maximal exercise performance, 
decreased blood glucose, elevated IL-6 at rest, and a reduction 
in physical activity in the 12 h after sleep deprivation. This 
increase in IL-6 may be mediated in part by altered glucose 
homeostasis. Neither partial nor complete sleep deprivation 
altered cytokine or neuroendocrine responses to exercise. 
However, perception of effort was significantly increased after 
24 h of sleep deprivation, which was also associated with var-
iations in the resting plasma concentrations of IL-6, sIL-6R, 
cortisol, and noradrenaline. Maximal exercise performance 
was impaired, likely through an increased perception of ef-
fort, which may be mediated in part by an increase in resting 
IL-6 concentration (Fig. 2A). With the exception of subjective 
fatigue and resting blood glucose, partial sleep deprivation 
had minimal effects on the responses measured in the current 
study; however, these findings should not be extrapolated to 
scenarios of chronic partial sleep deprivation. Taken together, 
these findings provide novel insights into the mechanisms that 
may contribute to an increased perception of effort and ulti-
mately impaired exercise performance after sleep deprivation. 
In accordance with previous studies, we have demonstrated 
that perception of effort, but not physiological responses to in-
tensity matched submaximal exercise, was affected by sleep 
deprivation, and that subsequent maximal aerobic exercise 
performance was impaired and coincided with significantly 
lower physiological responses (Fig. 3A) (3,22,23). These re-
sponses were also preceded by disruptions in mood and partic-
ularly subjective perception of fatigue (Table 1), which have 
routinely been observed in the context of impaired sleep (9). 
Interestingly, subjective fatigue before exercise and perception 
of effort during the submaximal exercise were both related to 
the mean V˙ O2 and distance cycled during maximal exercise, 
providing further evidence of their importance in exercise per-
formance. Importantly, sleep deprivation–induced elevations 
in IL-6 were associated with an increased perception of effort 
during exercise and exercise performance and the mean V˙ O2 
achieved during maximal exercise. Perhaps the most convinc-
ing evidence from the current study is that 22% of the variance 
in performance between conditions was accounted for by the 
change in resting IL-6 between conditions. Notably, when 
we examined the IL-6 response to exercise, there was no rela-
tionship to performance or the detrimental effects of sleep dep-
rivation; this seems to be yet another example of the subtle and 
context-dependent nature of IL-6 signaling. This is a signifi-
cant result given the highly complex and multifactorial nature 
of exercise performance. As such, it seems that IL-6 may play 
a role in impaired exercise performance after sleep depriva-
tion, potentially mediated via an increased perception of effort. 
Previous studies have shown that sleep deprivation–induced 
increases in IL-6 are associated with an increased perception 
of pain (24). Given the link between perception of effort and 
pain perception, it is highly plausible that the two phenomena 
may be linked or interact. It is feasible that perceived effort is 
increased in part by the pain-sensitizing effect of IL-6; how-
ever, this is somewhat speculative, and further work is re-
quired to investigate the potentially subtle role of IL-6 in 
mediating these responses. Furthermore, we demonstrated that 
resting blood glucose was lowered after both partial and com-
plete sleep deprivation (Fig. 2B), which was positively related 
to the increase in IL-6 (Fig. 2C). Given the established role of 
IL-6 in glucose metabolism (25), it is highly plausible that al-
terations in glucose metabolism are partly responsible for the 
increase in IL-6. The source of the increased plasma IL-6 after 
sleep deprivation remains poorly understood; however, it is 
feasible that skeletal muscle may be the source of additional 
IL-6 in this context given that IL-6 production by skeletal 
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muscle is influenced by muscle glycogen content (26), which 
has been shown to be reduced after sleep deprivation (27). 
With the exception of the aforementioned results for IL-6, 
the effects of sleep deprivation on sIL-6R and neuroendocrine 
factors measured in the current study were minimal. Contrary 
to findings from a recent epidemiological study (11), we found 
that the plasma concentration of BDNF was not reduced after 
sleep deprivation, but that lower concentrations of BDNF were 
related to negative changes in mood. As such, it is possible that 
sleep deprivation per se is not the direct cause of reduced BDNF 
reported in insomnia suffers or those with impaired sleep, and 
it is more likely that the accumulated psychological stress as-
sociated with insomnia results in decreased BDNF (7). Sleep 
deprivation had no discernible effect on sIL-6R, and this find-
ing is interesting considering the extremely limited and some-
what conflicting available evidence regarding the effect of 
sleep on sIL-6R. Dimitrov and colleagues (28) previously re-
ported that sleep deprivation abolished the sleep-induced in-
crease in sIL-6R, whereas in a longitudinal setting, our 
group previously reported that sIL-6R was positively related 
to subjectively reported sleep quality (15). Interestingly, recent 
evidence suggests that the relationship may be bidirectional in 
that sleep can also be affected by IL-6 trans-signaling through 
sIL-6R–mediated responses within the brain (29); this com-
plex interaction warrants further research in those with chronic 
sleep conditions. 
We found a main effect of sleep condition on plasma corti-
sol, which accounted for 29% of the variance in the resting 
values, with cortisol appearing higher after both partial and 
complete sleep deprivation (Fig. 4E); however, post hoc com-
parisons were not statistically significant. This seems some-
what reflective of previous studies as the effect of sleep 
deprivation on cortisol remain largely unclear, with studies 
having reported no effect (30), increased (31), and decreased 
(32) plasma cortisol concentration. However, in the current 
study, we observed a positive relationship between resting cor-
tisol concentration and RPE (r = 0.56), which is very similar to 
the correlation reported (r = 0.551) in a previous longitudinal 
study that assessed the relationship between cortisol and ses-
sion RPE (33). As such, cortisol responses to sleep deprivation 
remain unclear, but our results further emphasize the role of 
cortisol in effort perception. 
Similarly, we found no effect of sleep condition on the rest-
ing concentration of adrenaline or noradrenaline, which does 
appear in accordance with the apparent consensus (34). How-
ever, resting adrenaline concentration was negatively related 
to perception of fatigue at rest, whereas postexercise adrenaline 
concentration was positively related to exercise performance. 
These findings would appear in line with the established role 
of adrenaline in facilitating physical activity, but highlight the 
importance of subjective fatigue in this relationship. 
Similarly to IL-6, resting cortisol concentration was posi-
tively correlated with perception of effort during exercise. Taken 
together, it may be that, although adrenaline, noradrenaline, 
and cortisol are not affected by sleep deprivation per se, they  
do play a role in alterations of mood and effort perception 
during exercise. Furthermore, it seems that differences in 
exercise-induced adrenaline concentration also account for 
some variation in performance. This is important when consid-
ering recent evidence that individual differences in anxiety and 
psychological stress play a role in immune responses to exercise 
(35). Any interactions between sleep, mood, and immune– 
endocrine responses are likely to be complex and interdepen-
dent, and future studies should be carefully designed to examine 
potential interactions and investigate the direction of effects. 
It is well documented that sleep and physical activity share a 
bidirectional relationship (36) and can also be involved in de-
velopment of chronic health conditions such as diabetes or 
obesity (37). In this regard, we found that free-living energy 
expenditure was reduced in the 12 h after sleep deprivation 
and was negatively related to the level of subjective fatigue re-
ported by participants in the morning before exercise. It may 
be that an increased perception of fatigue, as a result of im-
paired sleep, may make exercise a less attractive prospect, 
therefore resulting in reduced levels of physical activity. If re-
peated, this could have important negative consequences for 
long-term health. However, it is important to stress that the 
current study examined responses to single-night sleep depri-
vation, and although this is similar to the quantity of sleep oc-
casionally experienced by athletes before competition (2) or 
the sleep deprivation experienced by night shift workers (38), 
it is not necessarily representative of more prolonged sleep dep-
rivation or chronic partial sleep deprivation. Given the increased 
prevalence of sleep deprivation and physical inactivity in 
modern society, this is an important finding and highlights 
the importance of subjective fatigue in the context of physical 
activity. Physical activity levels were not significantly differ-
ent in the 24-h period the day after the trial, suggesting that 
physical activity levels return to normal after one complete 
sleep cycle. As such, it is important to emphasize that the cur-
rent study focused specifically on acute sleep disturbance and 
that these findings should not be extrapolated to circumstances 
of chronic partial sleep deprivation, which may indeed be a 
more common scenario. In this regard, future studies are re-
quired to further investigate chronic partial sleep loss. 
In the current study, exercise-induced changes in cytokine 
and neuroendocrine factors were largely maintained after par-
tial and complete sleep deprivation. This is important consider-
ing that exercise-induced changes in IL-6 and BDNF (among a 
range of other factors) seem important for exercise-induced ad-
aptations in insulin sensitivity, lipolysis (39,40), and improved 
cognition and mood status (41). Furthermore, there is evidence 
from animal studies that chronic exercise training can negate 
the increase in circulating IL-6, which is induced by sleep 
deprivation (42), suggesting that exercise training may in fact 
prevent some of the negative effects of sleep deprivation via 
anti-inflammatory mechanisms. It is also possible that exercise-
induced elevations in BDNF may help to mitigate some of 
the deleterious effects that sleep deprivation can have on mood 
status and perceived well-being. It is important to emphasize 
that the effects observed in our study are likely multifactorial 
and highly complex, and as such, there are undoubtedly a wide 
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range of additional signaling factors that may also contribute 
to the observed responses. In this regard, we encourage fur-
ther study to further explain variations in perceived fatigue 
and mood disturbance, as a better mechanistic understanding 
may well lead to improved management of or countermea-
sures to sleep deprivation. 
In conclusion, the current study shows that elevated circu-
lating concentrations of IL-6 at rest seem to play a role in the 
well-established impairments in mood, perception of effort, 
and exercise performance experienced after sleep deprivation. 
In contrast, cortisol, adrenaline, noradrenaline, and BDNF 
were not affected by sleep deprivation but do seem to account 
for subtle variations in mood and effort perception. Neither 
partial nor 24 h of sleep deprivation affects the cytokine and 
neuroendocrine responses to exercise measured in this study. 
Furthermore, we found that free-living energy expenditure 
was reduced after 24 h of sleep deprivation and that the level 
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